SURVEY: Experimental Design & Data Analysis in Cardiovascular Safety Pharmacology Studies

You're Invited to Participate in our Survey Titled: Experimental Design and Data Analysis in Cardiovascular Safety Pharmacology Studies

The Safety Pharmacology Society (SPS) Best Practice Committee invites you to participate in their survey titled “Experimental Design and Data Analysis in Cardiovascular Safety Pharmacology Studies.”

The primary goal of the current survey is to establish current industry practices as they relate to experimental study design and post-acquisition data analysis for the conduct of in vivo cardiovascular safety pharmacology studies. The survey contains 26 questions and should take approximately 20 minutes to complete. Results will be shared with the Safety Pharmacology Society (SPS) membership as a scientific meeting poster presentation and manuscript.

To show our appreciation for your time, individuals who complete all the survey questions and provide their email address on the last page, will be included in a random selection prize drawing for an iPad!

Follow the link to access the survey. The survey deadline is October 10.

Safety Pharmacology Society Headquarters

Recent Stories
2018 SPS Bay Area Regional Meeting: Filling Translational Gaps in Safety Assessment—November 14, 2018

SPS Call for Volunteers: 2019 Program and CE Committees

Meeting of Interest: Cross-Company Abuse Liability Council (CCALC) “Advancements and Challenges in the Abuse Potential Evaluation” Conference